The Kerala government has launched an Artificial Intelligence (AI)-assisted chronic eye disease screening programme 'Nayanamritham 2.0'.
Through this initiative, the Kerala government is integrating artificial intelligence into the public health system.
It will provide advanced eye screening facilities to people across the state.
Key Points:
Nayanamritham 2.0 aims to detect serious eye diseases at an early stage.
It is the world's first government AI-powered eye screening programme.
The Kerala government launched it in collaboration with Remedio health-tech company.
Its first version focused on screening for diabetic retinopathy at Family Health Centres (FHCs).
Nayanamritam 2.0 will also enable identification of diseases like Glaucoma and Age-Related Macular Degeneration (AMD) along with Diabetic Retinopathy (DR).
It has now been implemented in Community Health Centres, Taluk Hospitals and District Hospitals as well.
Eye Diseases:
Glaucoma:
It is a chronic eye disease in which the optic nerve of the eye gets damaged and can lead to vision loss.
It is usually caused by increased internal pressure of the eyes (Intra-Ocular Pressure - IOP).
Diabetic Retinopathy:
It is a serious eye disease caused due to diabetes.
If not treated on time, it can lead to blindness.
Age-related macular degeneration (AMD):
It is an eye disease that affects the central part of the retina (macula) mainly in old age.
It can cause gradual or rapid loss of vision.
It causes difficulty in reading, writing, recognizing faces and seeing clearly.
Remidio Health-Tech Company:
This Indian company develops cutting-edge AI-enabled medical devices for early detection and screening of eye diseases.
The company focuses on preventing blindness and providing affordable eye health solutions.